Brief: Milestone Pharmaceuticals Q3 basic EPS USD -0.35
13/11/2023 11:58
Nov 13 (Reuters) - Milestone Pharmaceuticals Q3 basic EPS USD -0.35. * Q3 income from operations USD -15.36 million
Recent news on Milestone Pharmaceuticals
See all newsBrief: Milestone Pharmaceuticals Announces First European Study Participant Enrolled In Revera-301 Phase 3 Clinical Trial
Brief: Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment To The Co
Milestone Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Milestone Pharma misses Q2 product revenue expectations
Milestone Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview